Expert Investigative Journalism Advice with John Carreyrou — ONA18
In one of the biggest news stories of the year, Wall Street Journal reporter John Carreyrou exposed fraud by the founder of Theranos, a startup promising rapid blood testing and early disease detection. In a culmination of years of investigative work, Carreyrou published a bestselling book, Bad Blood: Secrets and Lies in a Silicon Valley Startup. We’ll walk through the reporting it took to bring a piece that spans science, health and big business to fruition, with expert advice on research and investigative techniques. We’ll be sure to leave plenty of time for Q&A.
Видео Expert Investigative Journalism Advice with John Carreyrou — ONA18 канала Online News Association
Видео Expert Investigative Journalism Advice with John Carreyrou — ONA18 канала Online News Association
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
WSJ journalist John Carreyrou shares year-long Theranos investigation & breaks latest, stunning newsHow Technology Changed Investigative Journalism | Sara Koenig | Google ZeitgeistPitch Showcase: Let’s Hear Your Wildest Product Idea for Journalism – ONA18Measuring the Impact of Engaged Journalism - ONA20 EverywhereSteven Levitt on child carseatsRonan Farrow: Is the Trump presidency causing irreparable damage to America?Mark Cuban | Full Q&A | Oxford Union23. Bad Blood - Interview with John CarreyrouThe Future of News: Journalism in a Post-Truth Era2020 ONA Community Award Announcement — Online Journalism AwardsIn His Own Words: The Theranos WhistleblowerCIA Chief Disguise Officer Opens UpHow to be an Investigative Journalist: Greg PalastThe lies our culture tells us about what matters --- and a better way to live | David BrooksBill Gates would start this kind of company todayWHCC TV 2019 Interview with Tyler Shultz, Theranos Whistleblower and EntrepreneurTriangulation 350: John Carreyrou, Bad BloodRock Center Student Lunch Series: Fraud in the Valley?Big Fat Nutrition Policy | Nina TeicholzElizabeth Holmes, CEO of Theranos, in Conversation with Sal Khan